TMO · Thermo Fisher Scientific Inc
United States · RS rating 90 · As of 2026-11-03
| Price | 698.34 USD |
|---|---|
| 1-day change | +2.3% |
| RS rating (overall / 1M / 3M / 12M) | 90 / 66 / 90 / 71 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 53 / 79 / 53 |
| Industry group (rank) | Medical-Research Eqp/Svc (46) |
| EPS growth Q/Q | +22.0% |
| Sales growth Q/Q | +9.8% |
| Distance from 52-week high | +1.5% |
| Market cap (USD) | $173.4B |